Woman and Man
- | Country :
- United States
- Spain
- | organs : -
- | Specialty : -
Extract
The primary objective of the study is to assess the activity of TPI 287 as single agent therapy for patients with advanced, unresectable pancreatic cancer after failure of gemcitabine-containing therapy. Activity of TPI 287 will be determined by the 6-month survival rate.
Inclusion criteria
- Pancreatic cancer